Shares of Futura Medical plc (LON:FUM – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1.22 and traded as high as GBX 1.35. Futura Medical shares last traded at GBX 1.22, with a volume of 2,402,059 shares changing hands.
Futura Medical Price Performance
The firm’s 50-day moving average price is GBX 1.22 and its 200-day moving average price is GBX 5.13. The company has a market cap of £7.12 million, a price-to-earnings ratio of -0.59 and a beta of 1.25.
Insider Transactions at Futura Medical
In related news, insider Harmesh Suniara sold 4,441,678 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total value of £88,833.56. Corporate insiders own 25.86% of the company’s stock.
Futura Medical Company Profile
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Recommended Stories
- Five stocks we like better than Futura Medical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
